MitoNEET (CISD1) Knockout Mice Show Signs of Striatal Mitochondrial Dysfunction and a Parkinson's Disease Phenotype

Werner J. Geldenhuys, Stanley A. Benkovic, Li Lin, Heather M. Yonutas, Samuel D. Crish, Patrick G. Sullivan, Altaf S. Darvesh, Candice M. Brown, Jason R. Richardson

Research output: Contribution to journalArticlepeer-review

51 Scopus citations


Mitochondrial dysfunction is thought to play a significant role in neurodegeneration observed in Parkinson's disease (PD), yet the mechanisms underlying this pathology remain unclear. Here, we demonstrate that loss of mitoNEET (CISD1), an iron-sulfur containing protein that regulates mitochondrial bioenergetics, results in mitochondrial dysfunction and loss of striatal dopamine and tyrosine hydroxylase. Mitochondria isolated from mice lacking mitoNEET were dysfunctional as revealed by elevated reactive oxygen species (ROS) and reduced capacity to produce ATP. Gait analysis revealed a shortened stride length and decreased rotarod performance in knockout mice, consistent with the loss of striatal dopamine. Together, these data suggest that mitoNEET KO mice exhibit many of the characteristics of early neurodegeneration in PD and may provide a novel drug discovery platform to evaluate compounds for enhancing mitochondrial function in neurodegenerative disorders.

Original languageEnglish
Pages (from-to)2759-2765
Number of pages7
JournalACS Chemical Neuroscience
Issue number12
StatePublished - Dec 20 2017

Bibliographical note

Publisher Copyright:
© 2017 American Chemical Society.


  • aging
  • drug discovery
  • mitoNEET
  • mitochondrial dysfunction

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Cognitive Neuroscience
  • Cell Biology


Dive into the research topics of 'MitoNEET (CISD1) Knockout Mice Show Signs of Striatal Mitochondrial Dysfunction and a Parkinson's Disease Phenotype'. Together they form a unique fingerprint.

Cite this